indiabrand.org 
The MMR (Measles, Mumps, Rubella) vaccine in India is available under various brand names, including M-M-RVAXPRO by Merck and Biovac MMR by the Serum Institute of India. Your healthcare provider can offer insights about the availability of these vaccines. These vaccines are recommended during childhood to prevent these three communicable diseases effectively. Always consult with a pediatrician for guidelines on vaccinations for your child.
Brands to consider
Tresivac
Tresivac is a prominent MMR vaccine brand in India, known for its effectiveness in providing protection against measles, mumps, and rubella. This vaccine is manufactured in facilities that adhere to high safety standards, ensuring quality and reliability. Extensive studies and data support its use in immunization programs, contributing to India's efforts in eradicating these infectious diseases. By choosing Tresivac, healthcare providers enhance the health of communities, contributing to lower transmission rates of these preventable diseases.
Priorix
Priorix is recognized as a leading MMR (measles, mumps, rubella) vaccine brand in India, developed by GlaxoSmithKline. This vaccine is recommended for children between the ages of 9 months to 15 years and is essential for preventing measles, mumps, and rubella, which can lead to serious health complications. The formulation of Priorix is designed to provide effective immunization with a single dose, supporting public health initiatives aimed at eradicating these diseases. Your healthcare provider may recommend Priorix as a trusted option for vaccination, contributing to herd immunity and the overall wellbeing of the community.
MMRII
MMRII, a brand of the measles, mumps, and rubella vaccine in India, is recognized for its safety and efficacy. It is part of the immunization schedule recommended by the World Health Organization (WHO) and the Indian Ministry of Health and Family Welfare. MMRII helps protect against serious diseases like measles, mumps, and rubella, which can lead to significant health complications. The vaccine is made under rigorous quality control standards, ensuring reliability for your child's health. Parents often choose MMRII due to its proven track record and widespread availability in healthcare facilities across India.
Trimovax
Trimovax is a well-recognized MMR vaccine brand in India, offering protection against measles, mumps, and rubella. Manufactured under strict quality control measures, it ensures safety and efficacy in immunization for children. The vaccine is part of the National Immunization Program, contributing to community immunity. Choosing Trimovax can support your child's health and aid in preventing outbreaks of these infectious diseases.
Measles Mumps Rubella Vaccine (Biovac)
Measles Mumps Rubella Vaccine (Biovac) is a recognized MMR vaccine brand in India, designed to provide immunity against three infectious diseases: measles, mumps, and rubella. This vaccine plays a crucial role in public health by preventing outbreaks and protecting vulnerable populations, particularly children. Biovac adheres to stringent safety and quality standards, ensuring that it effectively meets immunization guidelines set by health authorities. By choosing Biovac, you contribute to the overall effort to maintain herd immunity and reduce the incidence of these preventable diseases in the community.
Efficacy Rate
The efficacy rate of the MMR vaccine, which protects against measles, mumps, and rubella, is generally reported to be around 93% for measles and 78% for mumps after the first dose. In India, brands like MMRVAX prove to be vital in immunization programs aimed at controlling these diseases. Monitoring vaccine coverage and effectiveness contributes to public health initiatives. Ensuring that your child receives the vaccination according to the recommended schedule helps to achieve herd immunity within communities.
Immunization Schedule
The MMR vaccine, which protects against measles, mumps, and rubella, typically forms part of the immunization schedule in India. The first dose is generally recommended for children at 9 months of age, with a second dose administered between 16 to 24 months. The vaccination helps to prevent outbreaks of these diseases, improving public health. Brands like Merck's M-M-R II are often used as part of this immunization program. It's important for you to consult with your healthcare provider to confirm the schedule that best suits your child's needs.
Storage and Handling
Proper storage and handling of the MMR vaccine, like those produced by Serum Institute of India, involves maintaining a temperature between 2degC and 8degC. Ensure the vaccine remains in its original packaging to protect it from light. The vaccine must be monitored using a temperature log to ensure compliance with recommended storage practices. After reconstitution, it is vital to use the MMR vaccine within 6 hours if kept at room temperature. Proper waste disposal protocols should also be followed to minimize any potential health risks.
Dosage Recommendations
The MMR vaccine, commonly used for measles, mumps, and rubella prevention in India, is typically administered in two doses. The first dose is usually given between 9 to 12 months of age, while the second dose is recommended between 15 to 18 months. Brands like Mevac-MMR offer this vaccination, aligning with the immunization schedule provided by the Indian Ministry of Health and Family Welfare. For your child's vaccination, consult a healthcare professional to ensure adherence to local guidelines.
Safety Profile
The MMR vaccine, particularly the M-M-RVAXPRO brand available in India, is designed to protect against measles, mumps, and rubella. Common side effects include mild fever and rash, while more serious adverse reactions are rare. Monitoring systems in place ensure that vaccine safety is continuously assessed. Data from health agencies provide insights into the vaccine's performance and public health impact across various demographics. Your awareness of these factors can contribute to informed discussions about vaccination.